tiprankstipranks
Trending News
More News >
EXACT Therapeutics AS (DE:56F)
:56F
Germany Market
Advertisement

EXACT Therapeutics AS (56F) Income Statement

Compare
0 Followers

EXACT Therapeutics AS Income Statement

Last quarter (Q2 2022), EXACT Therapeutics AS's total revenue was $―, a decrease of ― from previous quarter. In Q2, EXACT Therapeutics AS's net income was $―. See EXACT Therapeutics AS’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 1.82M$ 1.08M$ 402.07K$ 125.50K$ 143.30K
EBITDA
$ -56.66M$ -31.98M$ -14.41M$ -7.45M$ -4.76M
Operating Income
$ -59.11M$ -34.70M$ -15.98M$ -7.62M$ -4.95M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -58.59M$ -33.09M$ -14.82M$ -7.59M$ -4.91M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

EXACT Therapeutics AS Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis